<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>RUNCOV : a one-pot triplex real-time RT-LAMP as a point-of-care diagnostic tool for detecting SARS-CoV-2</dc:title>
  <dc:creator>Rob&#xE8;ne, I.</dc:creator>
  <dc:creator>Jouen, E.</dc:creator>
  <dc:creator>Maillot-Lebon, V.</dc:creator>
  <dc:creator>Fenelon, B. T.</dc:creator>
  <dc:creator>Hascoat, J.</dc:creator>
  <dc:creator>Pecrix, Y.</dc:creator>
  <dc:creator>/Richard, Damien</dc:creator>
  <dc:creator>Jaffar-Bandjee, M. C.</dc:creator>
  <dc:creator>Mavingui, P.</dc:creator>
  <dc:creator>Chiroleu, F.</dc:creator>
  <dc:creator>Becker, N.</dc:creator>
  <dc:creator>Poubeau, P.</dc:creator>
  <dc:creator>Ramiandrisoa, M.</dc:creator>
  <dc:creator>Sin, M.</dc:creator>
  <dc:creator>Costet, L.</dc:creator>
  <dc:creator>Laurent, A.</dc:creator>
  <dc:creator>Laurent, P.</dc:creator>
  <dc:creator>Chabirand, A.</dc:creator>
  <dc:creator>Moreau, A.</dc:creator>
  <dc:creator>Reynaud, B.</dc:creator>
  <dc:creator>Jeuffrault, E.</dc:creator>
  <dc:creator>Cetre-Sossah, C.</dc:creator>
  <dc:subject>SARS-CoV-2</dc:subject>
  <dc:subject>triplex-RT-LAMP</dc:subject>
  <dc:subject>detection</dc:subject>
  <dc:subject>point-of-care testing</dc:subject>
  <dc:description>Given the risk of zoonotic disease emergence, including new SARS-CoV-2 variants of COVID-19, rapid diagnostic tools are urgently needed to improve the control of the spread of infectious diseases. A one-pot triplex real-time RT-LAMP (reverse-transcription-loop-mediated isothermal amplification) assay, based on two regions of the genome SARS-CoV-2-specifically the Orf1ab and N genes-along with one internal control, the human RNase P gene, was developed. The multiplexing relies on the distinct melting peaks produced during an annealing step. This tool, named RUNCOV, was compared to the gold-standard reverse-transcription real-time quantitative PCR (RT-qPCR) assay. A simple sample preparation step was designed alongside the assay, making it ready for use on site, as a point-of-care diagnostic tool. RUNCOV is rapid (typically less than 40 minutes), highly sensitive and specific. When tested on clinical samples with known SARS-CoV-2 status, its limit of detection (LOD) ranges between 5 and 20 copies per reaction and its diagnostic sensitivity (97.44%) and specificity (100%) values are high compared to the RT-qPCR gold standard. These results were supported with an extensive in silico analysis of over 14 million genomes, demonstrating this tool was capable of detecting all known SARS-CoV-2 variants, including the most recent ones KP.3.1.1 and BA2.86.1. This molecular assay is portable, as demonstrated when it was used successfully in La R&#xE9;union in different contexts outside the laboratory.</dc:description>
  <dc:date>2025</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010092872</dc:identifier>
  <dc:identifier>fdi:010092872</dc:identifier>
  <dc:identifier>Rob&#xE8;ne I., Jouen E., Maillot-Lebon V., Fenelon B. T., Hascoat J., Pecrix Y., Richard Damien, Jaffar-Bandjee M. C., Mavingui P., Chiroleu F., Becker N., Poubeau P., Ramiandrisoa M., Sin M., Costet L., Laurent A., Laurent P., Chabirand A., Moreau A., Reynaud B., Jeuffrault E., Cetre-Sossah C.. RUNCOV : a one-pot triplex real-time RT-LAMP as a point-of-care diagnostic tool for detecting SARS-CoV-2. 2025, 10 (1),  bpaf010 [16 p.]</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
